EUVIMEDEUVIMED entdecken
Crossref

The Market-Expanding Role of Regulatory Approval in Medicine

Ben Berger, Amitabh Chandra, Craig Garthwaite

Review of Economics and Statistics · 24.03.2026 · 1-28

DOI: 10.1162/rest.a.1741 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Review of Economics and Statistics, online erschienen am 24.03.2026. Verfasst von Ben Berger und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Regulatory review is often seen as a barrier to innovation, increasing costs and delaying new medicines. Yet approval may also expand markets by certifying quality and reducing uncertainty. We test this by studying FDA approval for follow-on indications—uses that physicians could already prescribe “offlabel” — and find approval raises use in newly approved diseases by 25 percent within a year, with larger increases in smaller off-label markets. Subsequent approvals in the same disease yield smaller gains. Our results suggest regulatory approval of medicines expands market size by increasing demand, rather than easing insurer-imposed restrictions, revealing limits to marketbased learning.

Zitieren

APA

Berger, B., Chandra, A., & Garthwaite, C. (2026). The Market-Expanding Role of Regulatory Approval in Medicine. Review of Economics and Statistics, 1-28. https://doi.org/10.1162/rest.a.1741

Vancouver

Berger B, Chandra A, Garthwaite C. The Market-Expanding Role of Regulatory Approval in Medicine. Review of Economics and Statistics. 2026:1-28. doi:10.1162/rest.a.1741

BibTeX
@article{Berger2026,
  author = {Berger, Ben and Chandra, Amitabh and Garthwaite, Craig},
  title = {The Market-Expanding Role of Regulatory Approval in Medicine},
  journal = {Review of Economics and Statistics},
  year = {2026},
  pages = {1--28},
  doi = {10.1162/rest.a.1741}
}
Kostenlos starten →